United States securities and exchange commission logo November 13, 2020 Tara Condon Vice President, Head of Legal Affairs BridgeBio Pharma, Inc. 421 Kipling Street Palo Alto, CA 94301 Re: BridgeBio Pharma, Inc. Registration Statement on Form S-4 Filed November 6, 2020 File No. 333-249944 Dear Ms. Condon: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Margaret Schwartz at 202-551-7153 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Thomas Greenberg, Esq.